Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gemcitabine and Cisplatin Chemotherapy”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00660270
What this trial is testing

Chemotherapy and Radiation Following Pancreatic Surgery

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 53
Not applicableStudy completedNCT01801644
What this trial is testing

Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Barmherzige Brüder Vienna 60
Testing effectiveness (Phase 2)Study completedNCT01185847
What this trial is testing

RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 90
Early research (Phase 1)WithdrawnNCT01702714
What this trial is testing

RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT01454089
What this trial is testing

Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer

Who this might be right for
Urologic NeoplasmsMetastatic Bladder CancerUrinary Tract Neoplasms
Achieve Life Sciences 183
Early research (Phase 1)Study completedNCT00678132
What this trial is testing

AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 23
Early research (Phase 1)Study completedNCT00003144
What this trial is testing

Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health 44
Early research (Phase 1)Study completedNCT00599755
What this trial is testing

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Who this might be right for
CarcinomaNon-small Cell Lung Cancer
Merck Sharp & Dohme LLC 68
Testing effectiveness (Phase 2)Study completedNCT01912053
What this trial is testing

Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Center Eugene Marquis 41
Testing effectiveness (Phase 2)UnknownNCT01417390
What this trial is testing

Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First People's Hospital of Foshan 80
Large-scale testing (Phase 3)Ended earlyNCT00526643
What this trial is testing

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
National Cancer Institute, Naples 57
Testing effectiveness (Phase 2)Study completedNCT00049348
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT01900158
What this trial is testing

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Who this might be right for
Cholangiocarcinoma
PCI Biotech AS 24
Post-approval studies (Phase 4)UnknownNCT01501136
What this trial is testing

Treatment of Natural Killer/T Cell Lymphoma-I/II

Who this might be right for
Nasal and Nasal-type NK/T-cell Lymphoma
Mingzhi Zhang 200
Testing effectiveness (Phase 2)Study completedNCT00003105
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00006028
What this trial is testing

Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT03967977
What this trial is testing

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
BeiGene 420
Large-scale testing (Phase 3)Study completedNCT00300586
What this trial is testing

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Hospices Civils de Lyon 842
Testing effectiveness (Phase 2)UnknownNCT01192633
What this trial is testing

Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma

Who this might be right for
SarcomaChemotherapy
Fudan University 40
Large-scale testing (Phase 3)Study completedNCT02546934
What this trial is testing

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Fudan University 254
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation